Nina Squires1, Adrian Wills, John Rowson. 1. Speech and Language Therapy Department, Queen's Medical Centre, Nottingham, UK. nina.squires@nuh.nhs.uk
Abstract
PURPOSE OF REVIEW: Drooling is a distressing symptom for adults with neurological conditions and can be challenging for health professionals. This review will consider the physical and psychosocial impact of drooling and will discuss the current management options including behavioural, pharmacological and surgical approaches. RECENT FINDINGS: A number of studies describe the use of botulinum toxin injections and irradiation of the salivary glands but no conclusive guidelines exist to recommend the most efficient dose or technique. The majority of saliva management studies focus on children with physical and/or cognitive disabilities and this evidence cannot be generalized to adults. There are relatively few studies that focus on saliva management in the adult neurological population. SUMMARY: Drooling is distressing for patients and their families. Ideally an individual would have easy access to the most efficient treatment with the fewest side effects. More evidence is now available but a lack of consensus on management approach, treatment dose and administration technique still exists. The symptom of drooling is best managed by a multidisciplinary team, starting with a conservative approach and then leading to more invasive procedures as appropriate.
PURPOSE OF REVIEW: Drooling is a distressing symptom for adults with neurological conditions and can be challenging for health professionals. This review will consider the physical and psychosocial impact of drooling and will discuss the current management options including behavioural, pharmacological and surgical approaches. RECENT FINDINGS: A number of studies describe the use of botulinum toxin injections and irradiation of the salivary glands but no conclusive guidelines exist to recommend the most efficient dose or technique. The majority of saliva management studies focus on children with physical and/or cognitive disabilities and this evidence cannot be generalized to adults. There are relatively few studies that focus on saliva management in the adult neurological population. SUMMARY: Drooling is distressing for patients and their families. Ideally an individual would have easy access to the most efficient treatment with the fewest side effects. More evidence is now available but a lack of consensus on management approach, treatment dose and administration technique still exists. The symptom of drooling is best managed by a multidisciplinary team, starting with a conservative approach and then leading to more invasive procedures as appropriate.
Authors: María T Gómez-Caravaca; María T Cáceres-Redondo; Ismael Huertas-Fernández; Laura Vargas-González; Fátima Carrillo; Manuel Carballo; Pablo Mir Journal: Neurol Sci Date: 2014-09-20 Impact factor: 3.307
Authors: Pierangelo Barbero; Marco Busso; Carlo Alberto Artusi; Stefania De Mercanti; Marco Tinivella; Andrea Veltri; Luca Durelli; Marinella Clerico Journal: J Vis Exp Date: 2016-11-09 Impact factor: 1.355
Authors: Pierangelo Barbero; Marco Busso; Marco Tinivella; Carlo Alberto Artusi; Stefania De Mercanti; Angele Cucci; Andrea Veltri; Paolo Avagnina; Andrea Calvo; Adriano Chio'; Luca Durelli; Marinella Clerico Journal: J Neurol Date: 2015-09-26 Impact factor: 4.849